Showing results (21-30 of 94) with videos related to
Sort By:
Pageof 10
Chemical Communications (Cambridge, England)|September 21, 2002
Ruthenium(III) readily abstracts NO from L-arginine, the physiological precursor to NO, in the presence of H2O2. A remarkably simple model system for NO synthasesC J Marmion, T Murphy, K B NolanMetallomics : Integrated Biometal Science|November 17, 2015
Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancerJames P Parker, Ziga Ude, Celine J MarmionJournal of Geriatric Psychiatry and Neurology|October 1, 1994
Prevalence of personality disorders in two geropsychiatric inpatient unitsV Molinari, A Ames, M EssaJournal of Surgical Oncology|January 1, 1981
Uterine sarcoma following adjuvant radiotherapy for rectal carcinomaP J Marmion, P M Goldfarb, T P YoungkinActa Ophthalmologica Scandinavica|January 9, 1999
Vascular resistance in primary open angle glaucomaM I Aldoori, V J Marmion, R N BairdBMC Medical Education|November 19, 2025
Approaches to learning in pre-medicine: a multi-university mixed-methods studyDeclan Gaynor, Fiza Rashid-Doubell, Celine J Marmion, et al.Dalton Transactions (Cambridge, England : 2003)|December 4, 2008
The reduction of platinum(IV) and palladium(IV) ions by 2,6-pyridinedihydroxamic acidDarren Griffith, Atish Chopra, Helge Müller-Bunz, et al.Current Topics in Medicinal Chemistry|December 8, 2004
Ruthenium as an effective nitric oxide scavengerCeline J Marmion, Beth Cameron, Clodagh Mulcahy, et al.Dalton Transactions (Cambridge, England : 2003)|June 14, 2016
Derivatisation of buforin IIb, a cationic henicosapeptide, to afford its complexation to platinum(ii) resulting in a novel platinum(ii)-buforin IIb conjugate with anti-cancer activityJ P Parker, M Devocelle, M P Morgan, et al.Aging & Mental Health|April 25, 2007
The after-death call to family members: a clinical perspectiveS LoboPrabhu, V Molinari, J Pate, et al.Pageof 10